Terumo Medical Corporation Executive and Leadership Team

John Pinto, the Chief Financial Officer at Terumo Medical Corporation, directs all fiscal planning and capital allocation strategies. Overseeing the financial health of the organization, the Chief Financial Officer ensures alignment with long-term growth objectives for hollow-fiber technology and blood-management systems. This leadership role involves managing complex budgetary requirements while supporting the expansion of endovascular therapy solutions across North American markets. By optimizing resource distribution and maintaining rigorous fiscal discipline, John Pinto directly impacts the company's ability to invest in research and development. Ultimately, Pinto secures the financial stability necessary to sustain market leadership in the competitive medical manufacturing sector, ensuring that every dollar spent advances the core mission of delivering superior clinical thermometers and specialized medical devices to healthcare providers worldwide.

Keiichi Amatatsu, the President at Terumo Medical Corporation, architects the overarching corporate strategy and drives organizational performance. Overseeing the integration of manufacturing processes for clinical thermometers and blood-management systems, the President ensures that operational output meets stringent quality standards. This leadership role involves coordinating with the Board to refine the market approach for endovascular therapy solutions within the United States. By fostering a culture of continuous improvement and technical precision, Keiichi Amatatsu directly impacts the company's competitive positioning in the medical device industry. Ultimately, Amatatsu maintains the strategic vision required to navigate complex regulatory environments while expanding the reach of hollow-fiber technology, ensuring that the organization remains at the forefront of medical innovation and patient care excellence.

Kota Yamamura, the President at Terumo Medical Corporation, manages the operational scaling and supply chain logistics for the company's diverse product lines. Overseeing the manufacturing efficiency of hollow-fiber technology and clinical thermometers, the President ensures that production capacity aligns with rising demand in the medical sector. This leadership role involves streamlining internal workflows to enhance the delivery of blood-management systems to hospitals and clinics. By optimizing manufacturing footprints and logistics networks, Kota Yamamura directly impacts the company's ability to maintain consistent supply levels across regional markets. Ultimately, Yamamura drives operational excellence by implementing lean manufacturing principles, ensuring that the organization remains agile and responsive to the evolving needs of healthcare providers while maintaining the highest standards of product quality and reliability.

Michael Martinelli, the Senior VP, Medcal Affairs & Chief Medical Officer at Terumo Medical Corporation, directs clinical research and medical safety protocols. Overseeing the scientific validation of endovascular therapy solutions, the Senior VP, Medcal Affairs & Chief Medical Officer ensures that all products adhere to the highest clinical standards. This leadership role involves collaborating with medical professionals to refine the application of hollow-fiber technology and blood-management systems in clinical settings. By bridging the gap between engineering and patient care, Michael Martinelli directly impacts the efficacy and safety of the company's medical product portfolio. Ultimately, Martinelli secures the trust of the medical community by providing evidence-based insights that guide the development of next-generation devices, ensuring that every innovation translates into improved health outcomes for patients across diverse clinical environments.